Anthony Tucker-Bartley, MD (@atuckerbartley) 's Twitter Profile
Anthony Tucker-Bartley, MD

@atuckerbartley

Let’s talk evidence | Opinions are my own | Anesthesiology resident @mghanesthesia | Graduate of @harvardmed

ID: 1398073757948956673

linkhttps://orcid.org/0000-0001-9124-3718 calendar_today28-05-2021 00:30:10

53 Tweet

188 Followers

263 Following

The MV3 Foundation (@mv3foundation) 's Twitter Profile Photo

We’re looking for professional mentors to lead our #BlackScholars in small group sessions. Time commitment is 1.5 hours a month. Sign up here: bit.ly/profdevmentor Questions? Email: [email protected] #medtwitter #mentorship #nonprofit

We’re looking for professional mentors to lead our #BlackScholars in small group sessions. Time commitment is 1.5 hours a month. Sign up here: bit.ly/profdevmentor 
Questions? Email: development@mv3foundation.org
#medtwitter #mentorship #nonprofit
Anesthesiology (@_anesthesiology) 's Twitter Profile Photo

#VisualAbstract in Anesthesiology - Balanced Opioid-free Anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or Intermediate Noncardiac Surgery 🖌️ ow.ly/pnkt50JON2b

#VisualAbstract in Anesthesiology - Balanced Opioid-free Anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or Intermediate Noncardiac Surgery 🖌️ ow.ly/pnkt50JON2b
Suhas Gondi (@suhas_gondi) 's Twitter Profile Photo

Our new paper in NEJM explores how value-based payment models have often been regressive - moving dollars away from patients, providers, and communities with fewer resources toward those with more - and how the new CMS Innovation Center ACO REACH model might help change that. 1/x

Our new paper in <a href="/NEJM/">NEJM</a> explores how value-based payment models have often been regressive - moving dollars away from patients, providers, and communities with fewer resources toward those with more - and how the new <a href="/CMSinnovates/">CMS Innovation Center</a> ACO REACH model might help change that. 1/x
Mass General Anesthesia (@mghanesthesia) 's Twitter Profile Photo

We were ranked the #1 anesthesiology training program in the U.S. by reputation on Doximity! We're grateful for our dedicated staff who work tirelessly to support resident growth & our extraordinary residents for their relentless commitment to education. 📷a few of our residents

We were ranked the #1 anesthesiology training program in the U.S. by reputation on Doximity! We're grateful for our dedicated staff who work tirelessly to support resident growth &amp; our extraordinary residents for their relentless commitment to education.

📷a few of our residents
Mass General Anesthesia (@mghanesthesia) 's Twitter Profile Photo

Research at #MGHanesthesia explores the biological and neurophysiological basis of postop #delirium and its connection to #Alzheimer's disease and related dementias. Read about the MINDDS Trial being led by Dr. Seun Johnson-Akeju, anesthetist-in-chief: fal.cn/3qTVT

Research at #MGHanesthesia explores the biological and neurophysiological basis of postop #delirium and its connection to #Alzheimer's disease and related dementias.

Read about the MINDDS Trial being led by Dr. Seun Johnson-Akeju, anesthetist-in-chief: fal.cn/3qTVT
NANS-RFS & Young Neuromodulators (@nansrfs) 's Twitter Profile Photo

NANS RFS-Young Neuromodulators Education Video Series: SCS Preoperative Considerations ⠀ We’re excited to continue rolling out our Education Video Series, using a short video format to review neuromodulation education within a structured curriculum.

Anesthesiology (@_anesthesiology) 's Twitter Profile Photo

The use of low-dose #ketamine infusion for the treatment of chronic #pain has expanded rapidly. However, a trial in neuropathic pain revealed neither ketamine or ketamine + magnesium affected pain relief or cognitive–emotional measures. ow.ly/fx8T50KH7Xz

Anthony Tucker-Bartley, MD (@atuckerbartley) 's Twitter Profile Photo

The CDC released the 2022 opioid prescribing guidelines which replace the 2016 recommendations. cdc.gov/mmwr/volumes/7… #ChronicPain #CDC

The CDC released the 2022 opioid prescribing guidelines which replace the 2016 recommendations.
 
cdc.gov/mmwr/volumes/7…

#ChronicPain #CDC
Anthony Tucker-Bartley, MD (@atuckerbartley) 's Twitter Profile Photo

How can pain specialists diagnose complex regional pain syndrome when symptoms wax and wane between office visits? Allow patients to journal their symptoms using infrared thermography. See our latest case report. pubmed.ncbi.nlm.nih.gov/36599019/ #CRPS #ChronicPain

IASP (@iasppain) 's Twitter Profile Photo

Join IASP in celebrating the achievements of Black pain professionals during #BlackHistoryMonth. Share the stories of those making an impact in the field of pain science and let's uplift their contributions to the world.

Join IASP in celebrating the achievements of Black pain professionals during #BlackHistoryMonth. Share the stories of those making an impact in the field of pain science and let's uplift their contributions to the world.
Mass General Anesthesia (@mghanesthesia) 's Twitter Profile Photo

Today is International Day of Women and Girls in Science. At #MGHanesthesia, we aim to foster a love for #STEM by partnering with local high schools to introduce students to hands-on training and simulation experiences. Here’s a throwback to our most recent event. #WomeninScience

Today is International Day of Women and Girls in Science. At #MGHanesthesia, we aim to foster a love for #STEM by partnering with local high schools to introduce students to hands-on training and simulation experiences. Here’s a throwback to our most recent event. #WomeninScience
Anthony Tucker-Bartley, MD (@atuckerbartley) 's Twitter Profile Photo

Very few disease modifying agents are available for patients with Fibrous dysplasia/McCune-Albright Syndrome. In our latest open access review we investigate this issue and discuss novel therapeutic targets: pubmed.ncbi.nlm.nih.gov/36768871/ #ChronicPain #RareDisease FD/MAS Alliance

Very few disease modifying agents are available for patients with Fibrous dysplasia/McCune-Albright Syndrome.

In our latest open access review we investigate this issue and discuss novel therapeutic targets: pubmed.ncbi.nlm.nih.gov/36768871/

#ChronicPain #RareDisease <a href="/FDysplasia/">FD/MAS Alliance</a>
Mass General Anesthesia (@mghanesthesia) 's Twitter Profile Photo

#MGHanesthesia researchers Nicolas Kumar, Andy Siemens, MD 🏳️‍🌈, Daniel Saddawi-Konefka, MD, MBA, & @davidhaomd, & colleagues investigated EZ-blockers as an alternative to left-sided double lumen tubes for lung isolation and one-lung ventilation during thoracic surgery. Read more: spklr.io/6011lHDz

#MGHanesthesia researchers <a href="/NicolasKumarMD/">Nicolas Kumar</a>, <a href="/asiemens894/">Andy Siemens, MD 🏳️‍🌈</a>, <a href="/DanSaddawi/">Daniel Saddawi-Konefka, MD, MBA</a>, &amp; @davidhaomd, &amp; colleagues investigated EZ-blockers as an alternative to left-sided double lumen tubes for lung isolation and one-lung ventilation during thoracic surgery.

Read more: spklr.io/6011lHDz
Claudia Sotillo (@claudsotillomd) 's Twitter Profile Photo

🙌🏼🙏🏼 THANK YOU to everyone who attended, asked questions, and made The Faces of Anesthesiology possible!!❣️🌈 Shout out 🎙️🗣️ to: Bree Dulaney Nick Davies, MD ASA® Abby Schirmer, MD Anthony Tucker-Bartley, MD Dlorean Lemon-Riggs @Lydi_DC #DEI #Match2024 #MedTwitter #AnesthesiaTwitter #ANES23

🙌🏼🙏🏼 THANK YOU to everyone who attended, asked questions, and made The Faces of Anesthesiology possible!!❣️🌈 Shout out 🎙️🗣️ to: <a href="/BreeDulaney/">Bree Dulaney</a> <a href="/NickolasDavies/">Nick Davies, MD</a> <a href="/ASALifeline/">ASA®</a> <a href="/AbigailSchirmer/">Abby Schirmer, MD</a> <a href="/ATuckerBartley/">Anthony Tucker-Bartley, MD</a> <a href="/DloreanR/">Dlorean Lemon-Riggs</a> @Lydi_DC #DEI #Match2024 #MedTwitter #AnesthesiaTwitter #ANES23